Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid type A receptor alpha1beta2gamma2S subtype is a pentameric ligand-gated ion channel that serves as the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system [1, 2]. It is composed of two alpha-1, two beta-2, and one gamma-2S (short splice variant) subunits arranged around a central chloride-selective pore [2, 7]. Activation by the endogenous neurotransmitter GABA leads to chloride influx, resulting in membrane hyperpolarization and a subsequent decrease in neuronal firing [1, 6]. This specific receptor configuration is the most abundant GABA_A receptor subtype in the brain and is the principal target for benzodiazepines, which bind at the alpha/gamma subunit interface to enhance GABA-mediated currents [2, 4]. The alpha-1 subunit within this complex is specifically linked to the sedative, hypnotic, and anticonvulsant properties of GABAergic drugs, while the gamma-2S subunit is crucial for receptor clustering at synapses and benzodiazepine sensitivity [4, 6]. Clinically, this receptor is targeted to treat conditions such as insomnia, anxiety, and epilepsy, though its modulation is also associated with side effects like sedation, ataxia, and the potential for physical dependence [6].
Positive allosteric modulation of the GABA-induced chloride current
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha1beta2gamma2S subtype (GABA_A receptor alpha1beta2gamma2S).